Dendritic cells, engineered to overexpress 25‐hydroxyvitamin D 1α‐hydroxylase and pulsed with a myelin antigen, provide myelin‐specific suppression of ongoing experimental allergic encephalomyelitis-Reference-Cited by-同舟云学术

Dendritic cells, engineered to overexpress 25‐hydroxyvitamin D 1α‐hydroxylase and pulsed with a myelin antigen, provide myelin‐specific suppression of ongoing experimental allergic encephalomyelitis

Published:2017-03-31 Issue:7 Volume:31 Page:2996-3006
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Li Chih‐Huang¹²³,Zhang Jintao¹⁴,Baylink David J.¹,Wang Xiaohua¹⁵,Goparaju Naga Bharani¹,Xu Yi¹,Wasnik Samiksha¹,Cheng Yanmei¹⁶,Berumen Edmundo Carreon¹,Qin Xuezhong¹⁷,William Lau Kin‐Hing¹⁷,Tang Xiaolei¹

Affiliation:

1. Division of Regenerative MedicineDepartment of MedicineLoma Linda UniversityLoma Linda California USA

2. Department of Emergency MedicineChang‐Gung Memorial HospitalLinkou Medical CenterTaoyuan Taiwan

3. Graduate Institute of Clinical Medical SciencesSchool of MedicineChang‐Gung UniversityTaoyuan Taiwan

4. Institute of Medical and Pharmaceutical SciencesZhengzhou UniversityHenan China

5. Division of Infectious DiseaseJinan Infectious Disease HospitalShandong UniversityJinan China

6. Yue Yang Hospital of Traditional Chinese and Western MedicineShanghai University of Traditional Chinese MedicineShanghai China

7. Musculoskeletal Disease CenterJerry L. Pettis Memorial Veterans Affairs Medical CenterLoma Linda UniversityLoma Linda California USA

Funder

Loma Linda University

Chang Gung Memorial Hospital

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201601243R

Reference57 articles.

1. Is it time for a new global classification of multiple sclerosis?

2. From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development

3. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

4. Progressive multifocal leukoencephalopathy after natalizumab monotherapy;Lindå, H., von Heijne A.;N. Engl. J. Med.,2009

5. Alemtuzumab for the treatment of relapsing–remitting multiple sclerosis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential of Anti-Inflammatory DC Immunotherapy in Improving Proteinuria in Type 2 Diabetes Mellitus;Vaccines;2024-08-27

2. Ex Vivo-Generated Tolerogenic Dendritic Cells: Hope for a Definitive Therapy of Autoimmune Diseases;Current Issues in Molecular Biology;2024-04-28

3. Alleviation of experimental autoimmune encephalomyelitis by transferring low RelB expression tolerogenic dendritic cells;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

4. Myasthenia Gravis and Vitamin D Serum Levels: A Systematic Review and Meta-analysis;CNS & Neurological Disorders - Drug Targets;2023-06

5. Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration;Immunotherapy Advances;2023-01-01